EUVIMEDEUVIMED entdecken
Crossref

Serum biochemical evaluation following administration of imidazolyl thiazolidinedione in streptozotocin-induced diabetic rats

Neda Shakour, Mohammad Reza Mahdinezhad, Mousa-Al-Reza Hadjzadeh, Amirhossein Sahebkar, Farzin Hadizadeh

Journal of Molecular Histology · 2024

DOI: 10.1007/s10735-024-10272-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2024. Verfasst von Neda Shakour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Thiazolidinediones, Hypoglycemic Agents, Oxidative Stress. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetes mellitus represents a prominent global health concern, characterized by a rising prevalence rate. Type 2 Diabetes Mellitus (T2DM) is purported to be associated with an intricate interplay of genetic, environmental, and lifestyle factors. While some progress have been made in T2DM management, controlling associated complications remains a great challenge in medicine. OBJECTIVES: This study investigated a synthesized Imidazolyl Thiazolidinedione antidiabetic agent (PA9), focusing on serum parameters. METHODS: Streptozotocin-induced diabetic rats (n = 6) were subjected to orally treatment with PA9 (synthesized by Shakour et al. in an equal dose of a standard drug, 0.011 mmol/kg). The study conducted to measure some specific serum factors, including lipid profiles, liver and kidney enzymes, cardiac enzymes, and oxidative stress markers, both before and after treatment. RESULTS: The study findings indicated that PA9 effectively ameliorates hyperlipidemia by significantly reducing total cholesterol and triglyceride levels in serum. Additionally, PA9 demonstrated hepatoprotective effects against TZD-induced injuries, as evidenced by decreased levels of alanine transaminase and, alkaline phosphatase. In addition, PA9 also exhibited a modulatory effect on a cardiac injury marker, creatine kinase MB. Moreover, PA9 demonstrated antioxidant properties by reducing oxidative stress markers and enhancing the activities of catalase, thiol, and superoxide dismutase. CONCLUSIONS: The synthesized TZD compound (PA9) stands out as a highly promising agent for the management of diabetes. Its significant antihyperlipidemic effects, preventive influences on organ injuries, and demonstrated efficacy in reducing oxidative stress marker (SOD) make it therapeutic agent in diabetes management. This study lays the groundwork for innovative strategies in diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalThiazolidinedionesHypoglycemic AgentsOxidative StressAnimalsRatsMaleBiomarkersLiverStreptozocinAntioxidantsDiabetes Mellitus, Type 2Blood GlucoseRats, WistarLipids

Stichwörter der Autor:innen

Antioxidant propertiesDiabetes mellitusLipid profileThiazolidinedione derivative

Substanzen

ThiazolidinedionesHypoglycemic AgentsBiomarkersStreptozocinAntioxidantsBlood GlucoseLipids

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.

Zitieren

APA

Shakour, N., Mahdinezhad, M. R., Hadjzadeh, M. A., Sahebkar, A., & Hadizadeh, F. (2024). Serum biochemical evaluation following administration of imidazolyl thiazolidinedione in streptozotocin-induced diabetic rats. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10272-8

Vancouver

Shakour N, Mahdinezhad MR, Hadjzadeh MA, Sahebkar A, Hadizadeh F. Serum biochemical evaluation following administration of imidazolyl thiazolidinedione in streptozotocin-induced diabetic rats. Journal of Molecular Histology. 2024. doi:10.1007/s10735-024-10272-8

BibTeX
@article{Shakour2024,
  author = {Shakour, Neda and Mahdinezhad, Mohammad Reza and Hadjzadeh, Mousa-Al-Reza and Sahebkar, Amirhossein and Hadizadeh, Farzin},
  title = {Serum biochemical evaluation following administration of imidazolyl thiazolidinedione in streptozotocin-induced diabetic rats},
  journal = {Journal of Molecular Histology},
  year = {2024},
  doi = {10.1007/s10735-024-10272-8}
}
Kostenlos starten →